Detecting Glioma, Meningioma, and Pituitary Tumors, and Normal Brain Tissues based on Yolov11 and Yolov8 Deep Learning Models
Ahmed M. Taha, Salah A. Aly, Mohamed F. Darwish · 2025
Read Detecting Glioma, Meningioma, and Pituitary Tumors, and Normal Brain Tissues based on Yolov11 and Yolov8 Deep Learning Models by Ahmed M. Taha, Salah A. Aly, Mohamed F. Darwish (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2504-00189.txt.
Introduction
Ahmed Taha, Salah Aly, and Mohamed Darwish published a computing paper in 2025 on sorting brain tumors in MRI scans with deep learning. Reading scans by hand is slow and error prone, and it needs rare expertise. The team fine-tuned two recent detection models to sort scans into four classes: no tumor, and three tumor types. They used a public contrast-enhanced MRI dataset.
Both tuned models scored above ninety-nine percent accuracy, ahead of a custom network built for the task. The authors present the results as proof that such models can give fast, precise sorting of brain tumors. They frame the work as support for better treatment planning through automated image reading.
Catalog record
| CREATOR | Ahmed M. Taha, Salah A. Aly, Mohamed F. Darwish |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 24 KB |
| VERSION | 1.0 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2504-00189
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Detecting Glioma, Meningioma, and Pituitary Tumors, and Normal Brain Tissues based on Yolov11 and Yolov8 Deep Learning Models Ahmed M. Taha, Salah A. Aly, Mohamed F. Darwish Abstract Accurate and quick diagnosis of normal brain tissue Glioma, Meningioma, and Pituitary Tumors is crucial for optimal treatment planning and improved medical results. Magnetic Resonance Imaging (MRI) is widely used as a non-invasive diagnostic tool for detecting brain abnormalities, including tumors. However, manual interpretation of MRI scans is often time-consuming, prone to human error, and dependent on highly specialized expertise. This paper proposes an advanced AI-driven technique to detecting glioma, meningioma, and pituitary brain tumors using YoloV11 and YoloV8 deep learning models. Methods: Using a transfer learning-based fine-tuning approach, we integrate cutting-edge deep learning techniques with medical imaging to classify brain tumors into four categories: No-Tumor, Glioma, Meningioma, and Pituitary Tumors. Results: The study utilizes the publicly accessible CE-MRI Figshare dataset and involves fine-tuning pre-trained models YoloV8 and YoloV11 of 99.49% and 99.56% accuraies; and customized CNN accuracy of 96.98%. The results validate the potential of CNNs in achieving high precision in brain tumor detection and classification, highlighting their transformative role in medical imaging and diagnostics. I Introduction Brain tumors represent one of the most critical challenges in modern medicine, owing to their complex detection and significant health implications. The advent of artificial intelligence (AI), particularly deep learning, has revolutionized the field of medical imaging by providing automated and highly accurate diagnostic systems. Convolutional Neural Networks (CNNs) have demonstrated exceptional performance in image classification tasks, enabling advancements in tumor detection and classification. Despite the success of pre-trained models such as ResNet, VGG, and MobileNet, questions remain about their optimal use and whether custom-built deep neural networks (DNNs) can surpass them in specific tasks like brain tumor classification. This study is dedicated to addressing critical questions in the field of brain tumor detection by conducting a comprehensive evaluation of various pre-trained models, including YOLO8, and YOLOv11, alongside custom-designed deep neural networks. The evaluation is carried out on multiple brain tumor datasets, with the overarching aim of identifying the most effective model for accurate identification and classification of brain tumors. A primary objective of this research is to assess the diagnostic performance of the Yolov8 and Yolov8 models in real-world scenarios and establish benchmarks for their accuracy, reliability, and computational efficiency. Additionally, this study seeks to explore and implement optimization techniques that can further enhance the diagnostic capabilities of the models under investigation. Fig. 1: The framework of our study A detailed analysis of comparison with different models will enable the development of strategies to overcome challenges and improve overall performance. Through this process, the work aspires to contribute to the development of robust, reliable, and efficient diagnostic tools for brain tumor detection, ultimately aiding in early and accurate medical diagnoses and improving patient outcomes. The main contributions of this work are stated as follows: 1. Proving that Optimized CNN Design can Surpass Pre-Trained Models for Brain Tumor Classification 2. YoloV11 and YoloV8 achieves Exceptional Accuracy in Brain Tumor Classification The remainder of this paper is organized as follows. Section II provides the datasets description. Section III presents into the specifics of the models employed in this research. Sections IV , V , VI present the performance metric and results of the pre-trained models. Section VII presents an in-depth review of the most recent and well-established studies in the field of brain tumor classification using machine learning and deep learning techniques. Section VIII summarizes and concludes this paper. II Datasets and Data Collection For this study, we curated a comprehensive dataset by filtering and combining three of the most recently published datasets relevant to brain tumor detection and classification. This integrated dataset was specifically designed to address our research objectives and provide a robust foundation for model training and evaluation. The curated dataset is organized into four distinct categories: No-Tumor, Glioma, Meningioma, and Pituitary. these three data sets are as follows, to see samples of the data Please follow up the link in the reference: TABLE I: 1st Dataset with 7023 images Class No. Images Percent. Training 80% Testing 20% No-Tumor 2000 28.4% 1595 405 Glioma 1621 23% 1321 300 Meningioma 1645 23.4% 1339 306 Pituitary 1757 25% 1457 300 The first dataset is published oct 2024 [ 1 ] , Among the selected datasets, one prominent source is the Brain Tumor Classification Dataset on Kaggle, it has 7024 images divided into the aforementioned four categories. This dataset comprises a substantial collection of Magnetic Resonance Imaging (MRI) scans of the brain. Notably, the MRI images in this dataset are presented in their raw form, without any pre-processing techniques applied, thus preserving the original data distribution and characteristics. The second one is published Nov 2024 [ 2 ] , To enhance the robustness and diversity of our dataset, we incorporated an additional publicly available dataset containing a significantly larger collection of images. This supplementary dataset comprises a total of 30,700 MRI images, systematically categorized into the aforementioned 4 categories. TABLE II: 2nd Dataset with 30.100 images Class No. Images Percent. Training 100% No-Tumor 5588 18.5% 5588 Glioma 7928 26.3% 7928 Meningioma 8900 29.5% 8900 Pituitary 7665 25.4% 7665 The final dataset is published Dec 2024 [ 3 ] , It was carefully selected to prioritize image quality and its impact on model performance. Although this dataset represents the smallest portion of our overall collection, it is of critical importance due to the high-resolution Magnetic Resonance Imaging (MRI) scans it contains. These high-quality images played a pivotal role in enhancing the accuracy and reliability of our deep learning models. This dataset comprises a total of 2,107 images, systematically divided into two primary subsets: Training and Testing. Each of these subsets is further categorized into the same four classes as previously described: No-Tumor, Glioma, Meningioma, and Pituitary. TABLE III: 3rd Dataset with 2107 images Class No. Images Percent. Training 80% Testing 20% No-Tumor 558 26.4% 437 121 Glioma 487 23.1% 397 90 Meningioma 493 23.4% 401 92 Pituitary 563 26.7% 473 90 The integration of this dataset was motivated by the need to expand the volume and variability of the training and testing samples, thereby improving the generalizability of our deep learning models. By including a larger number of images across all categories, this augmentation step ensures that the models are exposed to a wide range of anatomical variations, imaging conditions, and potential noise, which is crucial for developing a reliable and accurate classification system. Table III shows the class breakdown, including the training, validation, and test splits. III Methodology This section begins by providing a detailed overview of the historical development, theoretical foundations, and structural design of the pre-trained models utilized in the study, such as YOLOv8, and YOLOv11. III-A Data Pre-Processing To enhance the quality and ensure precise positional alignment of the dataset images, we employed a comprehensive series of preprocessing steps designed to address common challenges in medical imaging data. These steps were specifically tailored to mitigate the effects of noise, improve image clarity, and emphasize the critical features necessary for accurate brain tumor classification. By refining the visual quality and structural integrity of the input data, these enhancements played a pivotal role in